IFITM3 inhibits influenza a virus infection by preventing cytosolic entry

PLoS Pathogens

Volumn 7, Issue 10, 2011, Pages

  Feeley, Eric M ^a   Sims, Jennifer S ^a   John, Sinu P ^a   Chin, Christopher R ^a   Pertel, Thomas ^a   Chen, Li Mei ^b   Gaiha, Gaurav D ^a   Ryan, Bethany J ^a   Donis, Ruben O ^b   Elledge, Stephen J ^c,d   Brass, Abraham L ^a,e  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON INDUCIBLE TRANSMEMBRANE PROTEIN 3; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; RAB7 PROTEIN; UNCLASSIFIED DRUG; GAMMA INTERFERON; IFITM3 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ARTICLE; CELL SURFACE; CYTOSOL; ENDOSOME; GENE OVEREXPRESSION; HOST CELL; IMMUNE SYSTEM; INFLUENZA A; INFLUENZA VIRUS A; LYSOSOME; NONHUMAN; PHENOTYPE; VIRUS GENOME; VIRUS PARTICLE; VIRUS REPLICATION; ANIMAL; CHICKEN; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HELA CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INFLUENZA; METABOLISM; PATHOGENICITY; VIROLOGY; VIRUS ENTRY;

DENGUE VIRUS; INFLUENZA A VIRUS; WEST NILE VIRUS;

ANIMALS; CHICKENS; CYTOSOL; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERFERON-GAMMA; MEMBRANE PROTEINS; RNA-BINDING PROTEINS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 80055078235     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002337     Document Type: Article

References (61)

1. Ritzwoller DP, Bridges CB, Shetterly S, Yamasaki K, Kolczak M, et al. (2005) Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics 116: 153-159.
2. Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, et al. (2000) Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 284: 1655-1663.
3. Weinstock DM, Zuccotti G, (2009) The evolution of influenza resistance and treatment. JAMA 301: 1066-1069.
4. Calfee DP, Hayden FG, (1998) New approaches to influenza chemotherapy. Neuraminidase inhibitors. Drugs 56: 537-553.
5. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group (1998) Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet 352: 1877-1881.
6. Mercer J, Schelhaas M, Helenius A, (2010) Virus entry by endocytosis. Annu Rev Biochem 79: 803-833.
7. Lakadamyali M, Rust MJ, Zhuang X, (2004) Endocytosis of influenza viruses. Microbes Infect 6: 929-936.
8. Lazarowitz SG, Choppin PW, (1975) Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology 68: 440-454.
9. Garten W, Linder D, Rott R, Klenk HD, (1982) The cleavage site of the hemagglutinin of fowl plague virus. Virology 122: 186-190.
10. Melikyan GB, (2010) Driving a wedge between viral lipids blocks infection. Proc Natl Acad Sci U S A 107: 17069-17070.
11. Cros JF, Palese P, (2003) Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res 95: 3-12.
12. Martin K, Helenius A, (1991) Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67: 117-130.
13. Bui M, Wills EG, Helenius A, Whittaker GR, (2000) Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J Virol 74: 1781-1786.
14. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254.
15. Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, et al. (2010) Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463: 818-822.
16. Konig R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, et al. (2010) Human host factors required for influenza virus replication. Nature 463: 813-817.
17. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, et al. (2009) A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139: 1255-1267.
18. Jiang D, Weidner JM, Qing M, Pan XB, Guo H, et al. (2010) Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol 84: 8332-8341.
19. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, et al. (2011) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 7: e1001258.
20. Weidner JM, Jiang D, Pan XB, Chang J, Block TM, et al. (2010) Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol 84: 12646-12657.
21. Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR, (1984) Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38: 745-755.
22. Lewin AR, Reid LE, McMahon M, Stark GR, Kerr IM, (1991) Molecular analysis of a human interferon-inducible gene family. Eur J Biochem 199: 417-423.
23. Siegrist F, Ebeling M, Certa U, (2011) The small interferon-induced transmembrane genes and proteins. J Interferon Cytokine Res 31: 183-197.
24. Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF, (1992) The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 149: 2841-2850.
25. Smith RA, Young J, Weis JJ, Weis JH, (2006) Expression of the mouse fragilis gene products in immune cells and association with receptor signaling complexes. Genes Immun 7: 113-121.
26. Lange UC, Adams DJ, Lee C, Barton S, Schneider R, et al. (2008) Normal germ line establishment in mice carrying a deletion of the Ifitm/Fragilis gene family cluster. Mol Cell Biol 28: 4688-4696.
27. Lange UC, Saitou M, Western PS, Barton SC, Surani MA, (2003) The fragilis interferon-inducible gene family of transmembrane proteins is associated with germ cell specification in mice. BMC Dev Biol 3: 1.
28. Ropolo A, Tomasini R, Grasso D, Dusetti NJ, Cerquetti MC, et al. (2004) Cloning of IP15, a pancreatitis-induced gene whose expression inhibits cell growth. Biochem Biophys Res Commun 319: 1001-1009.
29. Evans SS, Collea RP, Leasure JA, Lee DB, (1993) IFN-alpha induces homotypic adhesion and Leu-13 expression in human B lymphoid cells. J Immunol 150: 736-747.
30. Moffatt P, Gaumond MH, Salois P, Sellin K, Bessette MC, et al. (2008) Bril: a novel bone-specific modulator of mineralization. J Bone Miner Res 23: 1497-1508.
31. Brem R, Oraszlan-Szovik K, Foser S, Bohrmann B, Certa U, (2003) Inhibition of proliferation by 1-8 U in interferon-alpha-responsive and non-responsive cell lines. Cell Mol Life Sci 60: 1235-1248.
32. Hanagata N, Li X, Morita H, Takemura T, Li J, et al. (2010) Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice. J Bone Miner Metab 29: 279-290.
33. Yount JS, Moltedo B, Yang YY, Charron G, Moran TM, et al. (2010) Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat Chem Biol 6: 610-614.
34. Khor R, McElroy LJ, Whittaker GR, (2003) The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells. Traffic 4: 857-868.
35. Konig R, Stertz S, Zhou Y, Inoue A, Heinrich Hoffmann H, et al. (2009) Human host factors required for influenza virus replication. Nature 463: 813-817.
36. Lamb RA, Krug RM, (2001) Orthomyxoviridae: The viruses and their replication.; In: Knipe D, Howley P, editors. Philadelphia Lippincott Williams and Wilkins.
37. Tobiume M, Lineberger JE, Lundquist CA, Miller MD, Aiken C, (2003) Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells. J Virol 77: 10645-10650.
38. Tscherne DM, Manicassamy B, Garcia-Sastre A, (2010) An enzymatic virus-like particle assay for sensitive detection of virus entry. J Virol Methods 163: 336-343.
39. Haller O, Kochs G, (2011) Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 31: 79-87.
40. Ronni T, Matikainen S, Sareneva T, Melen K, Pirhonen J, et al. (1997) Regulation of IFN-alpha/beta, MxA, 2′,5′-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells. J Immunol 158: 2363-2374.
41. Sieczkarski SB, Whittaker GR, (2003) Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 4: 333-343.
42. Lawe DC, Chawla A, Merithew E, Dumas J, Carrington W, et al. (2002) Sequential roles for phosphatidylinositol 3-phosphate and Rab5 in tethering and fusion of early endosomes via their interaction with EEA1. J Biol Chem 277: 8611-8617.
43. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, et al. (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282: 24131-24145.
44. Shi CS, Kehrl JH, (2010) TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy. Sci Signal 3: ra42.
45. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, et al. (2004) Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119: 753-766.
46. Dittmann J, Stertz S, Grimm D, Steel J, Garcia-Sastre A, et al. (2008) Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J Virol 82: 3624-3631.
47. Zimmermann P, Manz B, Haller O, Schwemmle M, Kochs G, (2011) The viral nucleoprotein determines mx sensitivity of influenza a viruses. J Virol 85: 8133-8140.
48. Ablasser A, Hornung V, (2011) Where, in antiviral defense, does IFIT1 fit? Nat Immunol 12: 588-590.
49. Pichlmair A, Lassnig C, Eberle CA, Gorna MW, Baumann CL, et al. (2011) IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA. Nat Immunol 12: 624-630.
50. Umbach JL, Yen HL, Poon LL, Cullen BR, (2010) Influenza A virus expresses high levels of an unusual class of small viral leader RNAs in infected cells. MBio 1 14: e00204-00210.
51. Saha BK, Graham MY, Schlessinger D, (1979) Acid ribonuclease from HeLa cell lysosomes. J Biol Chem 254: 5951-5957.
52. Rojek JM, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S, (2008) Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J Virol 82: 7677-7687.
53. van der Schaar HM, Rust MJ, Chen C, van der Ende-Metselaar H, Wilschut J, et al. (2008) Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog 4: e1000244.
54. Bernard E, Solignat M, Gay B, Chazal N, Higgs S, et al. (2010) Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments. PLoS One 5: e11479.
55. Mire CE, White JM, Whitt MA, (2010) A spatio-temporal analysis of matrix protein and nucleocapsid trafficking during vesicular stomatitis virus uncoating. PLoS Pathog 6: e1000994.
56. Meertens L, Bertaux C, Dragic T, (2006) Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J Virol 80: 11571-11578.
57. Uchil P, Mothes W, (2005) Viral entry: a detour through multivesicular bodies. Nat Cell Biol 7: 641-642.
58. Le Blanc I, Luyet PP, Pons V, Ferguson C, Emans N, et al. (2005) Endosome-to-cytosol transport of viral nucleocapsids. Nat Cell Biol 7: 653-664.
59. Lu J, Pan Q, Rong L, Liu SL, Liang C, (2011) The IFITM Proteins Inhibit HIV-1 Infection. J Virol 85: 2126-2137.
60. Pertel T, Hausmann S, Morger D, Zuger S, Guerra J, et al. (2011) TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472: 361-365.
61. Wan XF, Nguyen T, Davis CT, Smith CB, Zhao ZM, et al. (2008) Evolution of highly pathogenic H5N1 avian influenza viruses in Vietnam between 2001 and 2007. PLoS One 3: e3462.